Pierce A - Search Results

1

HMG20B stabilizes association of LSD1 with GFI1 on chromatin to confer transcription repression and leukemia cell differentiation block.

Maiques-Diaz A, Nicosia L, Basma NJ, Romero-Camarero I, Camera F, Spencer GJ, Amaral FMR, Simeoni F, Wingelhofer B, Williamson AJK, Pierce A, Whetton AD, Somervaille TCP. Maiques-Diaz A, et al. Among authors: pierce a. Oncogene. 2022 Oct;41(44):4841-4854. doi: 10.1038/s41388-022-02471-y. Epub 2022 Sep 28. Oncogene. 2022. PMID: 36171271 Free PMC article.

2

Macrophage inflammatory protein-1 alpha receptors are present on cells enriched for CD34 expression from patients with chronic myeloid leukemia.

Chasty RC, Lucas GS, Owen-Lynch PJ, Pierce A, Whetton AD. Chasty RC, et al. Among authors: pierce a. Blood. 1995 Dec 1;86(11):4270-7. Blood. 1995. PMID: 7492787 Free article.

3

Haemopoietic growth factors and leukaemogenesis.

Pierce A, Whetton AD. Pierce A, et al. Biochem Soc Trans. 1997 May;25(2):366-70. doi: 10.1042/bst0250366. Biochem Soc Trans. 1997. PMID: 9191119 Review. No abstract available.

4

An activated protein kinase C alpha gives a differentiation signal for hematopoietic progenitor cells and mimicks macrophage colony-stimulating factor-stimulated signaling events.

Pierce A, Heyworth CM, Nicholls SE, Spooncer E, Dexter TM, Lord JM, Owen-Lynch PJ, Wark G, Whetton AD. Pierce A, et al. J Cell Biol. 1998 Mar 23;140(6):1511-8. doi: 10.1083/jcb.140.6.1511. J Cell Biol. 1998. PMID: 9508782 Free PMC article.

5

p210 Bcr-Abl expression in a primitive multipotent haematopoietic cell line models the development of chronic myeloid leukaemia.

Pierce A, Owen-Lynch PJ, Spooncer E, Dexter TM, Whetton AD. Pierce A, et al. Oncogene. 1998 Aug 6;17(5):667-72. doi: 10.1038/sj.onc.1201969. Oncogene. 1998. PMID: 9704934

6

Activation of granulocyte-macrophage colony-stimulating factor and interleukin-3 receptor subunits in a multipotential hematopoietic progenitor cell line leads to differential effects on development.

Evans CA, Pierce A, Winter SA, Spooncer E, Heyworth CM, Whetton AD. Evans CA, et al. Among authors: pierce a. Blood. 1999 Sep 1;94(5):1504-14. Blood. 1999. PMID: 10477674 Free article.

7

Bcr-Abl protein tyrosine kinase activity induces a loss of p53 protein that mediates a delay in myeloid differentiation.

Pierce A, Spooncer E, Wooley S, Dive C, Francis JM, Miyan J, Owen-Lynch PJ, Dexter TM, Whetton AD. Pierce A, et al. Oncogene. 2000 Nov 16;19(48):5487-97. doi: 10.1038/sj.onc.1203940. Oncogene. 2000. PMID: 11114726

8

The effect of Bcr-Abl protein tyrosine kinase on maturation and proliferation of primitive haematopoietic cells.

Buckle AM, Mottram R, Pierce A, Lucas GS, Russell N, Miyan JA, Whetton AD. Buckle AM, et al. Among authors: pierce a. Mol Med. 2000 Oct;6(10):892-902. Mol Med. 2000. PMID: 11126203 Free PMC article.

9

The specific enhancement of interferon alpha induced growth inhibition by BCR/ABL only occurs in multipotent cells.

Pierce A, Smith DL, Jakobsen LV, Whetton AD, Spooncer E. Pierce A, et al. Hematol J. 2001;2(4):257-64. doi: 10.1038/sj.thj.6200114. Hematol J. 2001. PMID: 11920258

10

BCR-ABL alters the proliferation and differentiation response of multipotent hematopoietic cells to stem cell factor.

Pierce A, Spooncer E, Ainsworth S, Whetton AD. Pierce A, et al. Oncogene. 2002 May 2;21(19):3068-75. doi: 10.1038/sj.onc.1205424. Oncogene. 2002. PMID: 12082538

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

889 results

Search Page